News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MaxCyte, Inc. Presents Scalable Flow Electroporation as a Universal Platform for High Titer Antibody and Protein Production at CHI’s PEGS Europe Summit



11/4/2013 8:06:37 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is holding a series of events at Cambridge Health Institute’s Fifth Annual PEGS Europe Protein & Antibody Engineering Summit to be held November 4-8, 2013, at the Sheraton Hotel & Spa in Lisbon, Portugal. MaxCyte will present data in both podium and poster presentations emphasizing the universality of MaxCyte flow electroporation for the rapid, high titer production of antibodies and other proteins such as bi-specific antibodies, recombinant proteins, VLPs, and viral vectors

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES